180 related articles for article (PubMed ID: 22189044)
1. Effects of 22-oxa-calcitriol on podocyte injury in adriamycin-induced nephrosis.
Lydia A; Asanuma K; Nonaka K; Takagi M; Jeong KH; Kodama F; Asao R; Asanuma E; Prodjosudjadi W; Tomino Y
Am J Nephrol; 2012; 35(1):58-68. PubMed ID: 22189044
[TBL] [Abstract][Full Text] [Related]
2. Dendrin location in podocytes is associated with disease progression in animal and human glomerulopathy.
Asanuma K; Akiba-Takagi M; Kodama F; Asao R; Nagai Y; Lydia A; Fukuda H; Tanaka E; Shibata T; Takahara H; Hidaka T; Asanuma E; Kominami E; Ueno T; Tomino Y
Am J Nephrol; 2011; 33(6):537-49. PubMed ID: 21606645
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with telmisartan and oxacalcitriol suppresses the progression of murine adriamycin nephropathy.
Jeong KH; Asanuma K; Lydia A; Takagi M; Asao R; Kodama F; Asanuma E; Tomino Y
Nephron; 2015; 129(2):143-54. PubMed ID: 25661164
[TBL] [Abstract][Full Text] [Related]
4. Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats.
Matsui I; Hamano T; Tomida K; Inoue K; Takabatake Y; Nagasawa Y; Kawada N; Ito T; Kawachi H; Rakugi H; Imai E; Isaka Y
Nephrol Dial Transplant; 2009 Aug; 24(8):2354-61. PubMed ID: 19297354
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of Huang Qi Huai granules on adriamycin nephrosis in rats.
Zhu C; Huang S; Ding G; Yuan Y; Chen Q; Pan X; Chen R; Zhang A
Pediatr Nephrol; 2011 Jun; 26(6):905-13. PubMed ID: 21359962
[TBL] [Abstract][Full Text] [Related]
6. Re-expression of Sall1 in podocytes protects against adriamycin-induced nephrosis.
Hosoe-Nagai Y; Hidaka T; Sonoda A; Sasaki Y; Yamamoto-Nonaka K; Seki T; Asao R; Tanaka E; Trejo JAO; Kodama F; Takagi M; Tada N; Ueno T; Nishinakamura R; Tomino Y; Asanuma K
Lab Invest; 2017 Nov; 97(11):1306-1320. PubMed ID: 28759006
[TBL] [Abstract][Full Text] [Related]
7. α-Actinin-4 is involved in the process by which dexamethasone protects actin cytoskeleton stabilization from adriamycin-induced podocyte injury.
Liu H; Gao X; Xu H; Feng C; Kuang X; Li Z; Zha X
Nephrology (Carlton); 2012 Nov; 17(8):669-75. PubMed ID: 22804863
[TBL] [Abstract][Full Text] [Related]
8. 1, 25-dihydroxyvitamin D3 decreases adriamycin-induced podocyte apoptosis and loss.
Zou MS; Yu J; Nie GM; He WS; Luo LM; Xu HT
Int J Med Sci; 2010 Aug; 7(5):290-9. PubMed ID: 20827429
[TBL] [Abstract][Full Text] [Related]
9. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
Okada T; Sakaguchi T; Hatamura I; Saji F; Negi S; Otani H; Muragaki Y; Kawachi H; Shigematsu T
Clin Exp Nephrol; 2009 Oct; 13(5):438-446. PubMed ID: 19452240
[TBL] [Abstract][Full Text] [Related]
10. Protective role of cyclosporine A and minocycline on mitochondrial disequilibrium-related podocyte injury and proteinuria occurrence induced by adriamycin.
Guan N; Ren YL; Liu XY; Zhang Y; Pei P; Zhu SN; Fan Q
Nephrol Dial Transplant; 2015 Jun; 30(6):957-69. PubMed ID: 25646018
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
[TBL] [Abstract][Full Text] [Related]
12. Diversities of podocyte molecular changes induced by different antiproteinuria drugs.
Xing Y; Ding J; Fan Q; Guan N
Exp Biol Med (Maywood); 2006 May; 231(5):585-93. PubMed ID: 16636307
[TBL] [Abstract][Full Text] [Related]
13. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats.
Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S
Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701
[TBL] [Abstract][Full Text] [Related]
14. Zona occludens-2 protects against podocyte dysfunction induced by ADR in mice.
Bautista-García P; Reyes JL; Martín D; Namorado MC; Chavez-Munguía B; Soria-Castro E; Huber O; González-Mariscal L
Am J Physiol Renal Physiol; 2013 Jan; 304(1):F77-87. PubMed ID: 23034938
[TBL] [Abstract][Full Text] [Related]
15. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.
Marshall CB; Krofft RD; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2010 May; 298(5):F1140-51. PubMed ID: 20130121
[TBL] [Abstract][Full Text] [Related]
16. Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy.
Sun YB; Qu X; Zhang X; Caruana G; Bertram JF; Li J
PLoS One; 2013; 8(1):e55027. PubMed ID: 23359116
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
[TBL] [Abstract][Full Text] [Related]
18. Dysfunction of the PGC-1α-mitochondria axis confers adriamycin-induced podocyte injury.
Zhu C; Xuan X; Che R; Ding G; Zhao M; Bai M; Jia Z; Huang S; Zhang A
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1410-7. PubMed ID: 24808537
[TBL] [Abstract][Full Text] [Related]
19. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
[TBL] [Abstract][Full Text] [Related]
20. Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury.
He W; Kang YS; Dai C; Liu Y
J Am Soc Nephrol; 2011 Jan; 22(1):90-103. PubMed ID: 21030600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
